Post Resch Tallon Group Inc.

Position in EXEL — Exelixis, Inc.

CIK 2054476 PITTSFORD, NY

Position in EXEL

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$2,742,100

+$306,077 QoQ

Shares Held

50,397

-11.3% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

4.54%

of 13F equity value

Holder Rank

#36

of 228 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Post Resch Tallon Group Inc. holds $4,357,094 across 5 Biotechnology names. EXEL ranks #1 (62.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	50,397	$2,742,100
2	CDXS	Codexis, Inc.	563,478	$1,273,460
3	SNDX	Syndax Pharmaceuticals Inc	12,500	$273,250
4	AGEN	Agenus Inc	12,750	$39,015
5	CRDF	Cardiff Oncology, Inc.	22,515	$29,269

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,742,100	50,397	-11.3%	Shares	Sole	2026-07-07
2026-03-31	$2,436,023	56,797	+8.9%	Shares	Sole	2026-04-08
2025-12-31	$2,286,874	52,176	-27.5%	Shares	Sole	2026-01-09
2025-09-30	$2,970,461	71,924	-1.2%	Shares	Sole	2025-11-05
2025-06-30	$3,209,376	72,808	-5.3%	Shares	Sole	2025-07-09
2025-03-31	$2,838,815	76,891	-0.4%	Shares	Sole	2025-04-23
2024-12-31	$2,569,627	77,166	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.